Cargando…

Nuclear Transport Deficits in Tau-Related Neurodegenerative Diseases

Tau is a cytosolic microtubule binding protein that is highly abundant in the axons of the central nervous system. However, alternative functions of tau also in other cellular compartments are suggested, for example, in the nucleus, where interactions of tau with specific nuclear entities such as DN...

Descripción completa

Detalles Bibliográficos
Autores principales: Diez, Lisa, Wegmann, Susanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546323/
https://www.ncbi.nlm.nih.gov/pubmed/33101165
http://dx.doi.org/10.3389/fneur.2020.01056
_version_ 1783592208248602624
author Diez, Lisa
Wegmann, Susanne
author_facet Diez, Lisa
Wegmann, Susanne
author_sort Diez, Lisa
collection PubMed
description Tau is a cytosolic microtubule binding protein that is highly abundant in the axons of the central nervous system. However, alternative functions of tau also in other cellular compartments are suggested, for example, in the nucleus, where interactions of tau with specific nuclear entities such as DNA, the nucleolus, and the nuclear envelope have been reported. We would like to review the current knowledge about tau–nucleus interactions and lay out possible neurotoxic mechanisms that are based on the (pathological) interactions of tau with the nucleus.
format Online
Article
Text
id pubmed-7546323
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-75463232020-10-22 Nuclear Transport Deficits in Tau-Related Neurodegenerative Diseases Diez, Lisa Wegmann, Susanne Front Neurol Neurology Tau is a cytosolic microtubule binding protein that is highly abundant in the axons of the central nervous system. However, alternative functions of tau also in other cellular compartments are suggested, for example, in the nucleus, where interactions of tau with specific nuclear entities such as DNA, the nucleolus, and the nuclear envelope have been reported. We would like to review the current knowledge about tau–nucleus interactions and lay out possible neurotoxic mechanisms that are based on the (pathological) interactions of tau with the nucleus. Frontiers Media S.A. 2020-09-25 /pmc/articles/PMC7546323/ /pubmed/33101165 http://dx.doi.org/10.3389/fneur.2020.01056 Text en Copyright © 2020 Diez and Wegmann. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Diez, Lisa
Wegmann, Susanne
Nuclear Transport Deficits in Tau-Related Neurodegenerative Diseases
title Nuclear Transport Deficits in Tau-Related Neurodegenerative Diseases
title_full Nuclear Transport Deficits in Tau-Related Neurodegenerative Diseases
title_fullStr Nuclear Transport Deficits in Tau-Related Neurodegenerative Diseases
title_full_unstemmed Nuclear Transport Deficits in Tau-Related Neurodegenerative Diseases
title_short Nuclear Transport Deficits in Tau-Related Neurodegenerative Diseases
title_sort nuclear transport deficits in tau-related neurodegenerative diseases
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546323/
https://www.ncbi.nlm.nih.gov/pubmed/33101165
http://dx.doi.org/10.3389/fneur.2020.01056
work_keys_str_mv AT diezlisa nucleartransportdeficitsintaurelatedneurodegenerativediseases
AT wegmannsusanne nucleartransportdeficitsintaurelatedneurodegenerativediseases